Trials / Completed
CompletedNCT02859090
Study of the Expression of Heat Shock Proteins in Populations of B Lymphocytes in Human Tonsils
Single-centre Study of the Expression of Heat Shock Proteins in the Lymphocytes From the Tonsils of Patients With Various Diseases Requiring Tonsillectomy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
It has recently been shown that various HSPs are strongly expressed in B lymphomas. Indeed, HSP90 stabilizes the protein Bcl-6 in diffuse large-cell B lymphomas. Pharmacological inhibition of HSP90 in vitro induced apoptosis in lymphoma cells (Cerchietti et al. Nat. Medicine, 2009, 1369-1376). In addition, HSP110 is strongly expressed in non-Hodgkin lymphomas, and targeting this HSP at the cell surface using specific antibodies could constitute a future therapy (Zappasodi et al. Blood, 2011, 4421-4430). Despite the importance of these proteins in the development of lymphomas, their expression and their role in the activation of normal B lymphocytes and the normal development of germinal centres is not known. The expression of Heat shock proteins should vary among the different B lymphocyte populations present in the tonsils (naïve B cells, memory B cells, germinal centre B cells). The aim of this study is to establish an expression profile for heat shock proteins in populations of B lymphocytes in human tonsils
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | tonsillectomy | |
| BIOLOGICAL | blood sample |
Timeline
- Start date
- 2014-08-26
- Primary completion
- 2014-11-20
- Completion
- 2014-11-20
- First posted
- 2016-08-08
- Last updated
- 2019-01-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02859090. Inclusion in this directory is not an endorsement.